Publications
Specialty
Search
Wound Care
09/10/2024
ChartPath and WoundZoom announced a strategic partnership to enhance wound care management in long-term and post-acute care by combining ChartPath's user-friendly EHR platform with WoundZoom's advanced wound care technology.
Wound Care
09/10/2024
RedDress announced that ActiGraft Pro demonstrated exceptional efficacy in facilitating healing for chronic neuropathic DFUs. ActiGraft Pro showed significant superiority, with 2.73 greater odds of reaching complete wound closure by week 12 compared to the control (SoC).
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/10/2024
The technology underlying the Auryon Atherectomy System has been shown in clinical studies to be effective in treating lesions ranging from soft plaque to severely calcified[1-3].
Neurology
09/10/2024
Patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping demonstrated unprecedented dystrophin expression and functional improvement with the investigational therapeutic DYNE-251.
Veterans Health Today
09/10/2024
Adjuvant chemotherapy significantly improves disease-free survival (DFS) for patients with muscle-invasive upper tract urothelial cancer (UTUC), according to study results published in the Journal of Clinical Oncology.
Integrated Healthcare Executive
09/10/2024
Obesity significantly increases the risk of contracting COVID-19 upon exposure to the virus, with a 34% higher odds of testing positive compared to non-obese individuals, according to a study published in PNAS Nexus.
First Report Managed Care
09/10/2024
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy, according to an article published in the Journal of Clinical Oncology.
Psych Congress Network
09/10/2024
Put your clinical knowledge to the test with this quiz!
First Report Managed Care
09/10/2024
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a study published in JAMA Network Open.
Psych Congress Network
09/10/2024
Put your clinical knowledge to the test with this quiz!
EP Lab Digest
09/10/2024
iRhythm Technologies Press Release
Wounds, Wound Care
09/10/2024
Objective: To use real-world data on dressing change practices and clinical outcomes to examine whether a built-in indicator on a proprietary soft silicone multilayer foam dressing could reduce unnecessary dressing changes.
EP Lab Digest
09/10/2024
During National Atrial Fibrillation Awareness Month, experts share advice to help patients collaborate with their healthcare provider when making decisions about care
Vascular Disease Management
09/10/2024
Watch as Dr. Barry Katzen, president and founding board member of the CLI Global Society, discusses the importance of membership in the Society.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/10/2024
“Rurality creates unique challenges in delivering high quality cardiovascular care and eliminating health inequities. The ACC Board of Trustees Health Equity Task Force Action Plan outlines implementation strategies that address these challenges,” said Paul L. Douglass, MD, MACC.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/10/2024
"The Genetesis MICRO 2.0 trial offers an exciting opportunity to explore non-invasive diagnostic tools to help diagnose microvascular dysfunction that could transform how we approach cardiac care," said Dr. Ankitkumar Patel.
Oncology
09/10/2024
According to results from the phase 2 POTENTIAL study, neoadjuvant nivolumab demonstrated efficacy and safety among patients with stage I non-small cell lung cancer, at high-risk of recurrence.
Oncology
09/10/2024
According to results from the phase 2b REZILIENT1 study, zipalertinib demonstrated promising anti-tumor activity among patients with EGFR exon 20 insertion-mutated non-small cell lung cancer who experienced disease progression after treatment with amivantamab.
Cath Lab Digest
09/10/2024
Faraday has selected FDY-5301 for investigation in the belief that its properties are well-suited to mitigate ischemia-reperfusion injury (IRI). In preclinical IRI models, FDY-5301 reduced tissue damage, infarct size, and inflammation.
Podiatry Today
09/10/2024
Dr. Piselli discusses nutritional considerations that may contribute to addressing athletes in podiatric practice.